Cambridge fertility firm hopes NASDAQ move will expand investor base – Boston Herald
 MarketWatch (press release) |
Cambridge fertility firm hopes NASDAQ move will expand investor base
Boston Herald Cambridge-based OvaScience's pending transition to the NASDAQ stock exchange will expand its investor base as the life sciences company prepares for the commercial launch of its first product to help women conceive more easily via in vitro … OvaScience to move to Nasdaq on April 30 OvaScience Announces Listing on NASDAQ Under Ticker Symbol "OVAS" |
